{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:34:02Z","timestamp":1648686842464},"reference-count":43,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":917,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1111\/ijcp.12088","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T09:28:03Z","timestamp":1361870883000},"page":"527-535","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Extended-release niacin\/laropiprant for lipid management: observational study in clinical practice"],"prefix":"10.1155","volume":"67","author":[{"given":"E.","family":"Steinhagen-Thiessen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"D\u00e4nschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Buffleben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Smolka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pittrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Hildemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2013,2,26]]},"reference":[{"key":"10.1111\/ijcp.12088-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"Cleeman","year":"2001","journal-title":"J Am Med Ass"},{"key":"10.1111\/ijcp.12088-BIB2|cit2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/ijcp.12088-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archinternmed.2010.182","article-title":"Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants","volume":"170","author":"Ray","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1111\/ijcp.12088-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12088-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12088-BIB6|cit6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12088-BIB7|cit7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jacc.2007.10.038","article-title":"Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial","volume":"51","author":"Miller","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/ijcp.12088-BIB8|cit8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/ijcp.12088-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology","volume":"28","author":"Bassand","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1111\/ijcp.12088-BIB10|cit10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9149(97)00965-X","article-title":"Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)","volume":"81","author":"Jones","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1111\/ijcp.12088-BIB11|cit11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00045391-200401000-00011","article-title":"Optimizing LDL-C lowering with statins","volume":"11","author":"McKenney","year":"2004","journal-title":"Am J Ther"},{"key":"10.1111\/ijcp.12088-BIB12|cit12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/DHPS.S7302","article-title":"Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia","volume":"2","author":"Viljoen","year":"2010","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1111\/ijcp.12088-BIB13|cit13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1559-4572.2008.00050.x","article-title":"Mechanisms of flushing due to niacin and abolition of these effects","volume":"11","author":"Sood","year":"2009","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1111\/ijcp.12088-BIB14|cit14","unstructured":"European Medicines Agency (EMA) Tredaptive summary of product characteristics http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000889\/WC500042216.pdf"},{"key":"10.1111\/ijcp.12088-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2165\/11203730-000000000-00000","article-title":"Extended-release niacin (nicotinic acid)\/laropiprant","volume":"69","author":"Perry","year":"2009","journal-title":"Drugs"},{"key":"10.1111\/ijcp.12088-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1742-1241.2008.01938.x","article-title":"Lipid-modifying efficacy and tolerability of extended-release niacin\/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia","volume":"62","author":"Maccubbin","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1111\/ijcp.12088-BIB17|cit17","first-page":"90","article-title":"Efficacy and safety profile of co-administered ER niacin\/laropiprant and simvastatin in dyslipidaemia","volume":"16","author":"Gleim","year":"2009","journal-title":"Br J Cardiol"},{"key":"10.1111\/ijcp.12088-BIB18|cit18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amjcard.2009.02.047","article-title":"Flushing profile of extended-release niacin\/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease","volume":"104","author":"Maccubbin","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1111\/ijcp.12088-BIB19|cit19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.amjcard.2007.10.023","article-title":"Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia","volume":"101","author":"Paolini","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1111\/ijcp.12088-BIB20|cit20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000228585","article-title":"Flushing profile of extended-release niacin\/laropiprant at initiation of therapy in Asian lipid clinic patients","volume":"114","author":"Kush","year":"2009","journal-title":"Cardiology"},{"key":"10.1111\/ijcp.12088-BIB21|cit21","unstructured":"European Epidemiology Federation. Good Epidemiological Practice (GEP) Proper conduct in epidemiologic research. Updated 2007 http:\/\/www.ieaweb.org\/index.php?view=article&catid=20%3Agood-epidemiological-practice-gep&id=15%3Agood-epidemiological-practice-gep&format=pdf&option=com_content&Itemid=43"},{"key":"10.1111\/ijcp.12088-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/ijcp.12088-BIB23|cit23","volume-title":"Arzneiverordnungs-Report 2009","author":"Klose","year":"2009"},{"key":"10.1111\/ijcp.12088-BIB24|cit24","unstructured":"MSD Sharp & Dohme GmbH. Zocor\/Zocor forte (Simvastatin) Prescribing information (summary of product characteristics), February 2011 http:\/\/www.fachinfo.de"},{"key":"10.1111\/ijcp.12088-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.860","article-title":"Pattern of prescriptions issued by nursing home based physicians versus office-based physicians for frail elderly patients in German nursing homes","volume":"12","author":"Pittrow","year":"2003","journal-title":"Pharmacoepidem Drug Saf"},{"key":"10.1111\/ijcp.12088-BIB26|cit26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00063-006-1093-x","article-title":"Pr\u00e4valenz, medikament\u00f6se Behandlung und Einstellung des Diabetes mellitus in der Hausarztpraxis","volume":"101","author":"Pittrow","year":"2006","journal-title":"Med Klin (Munich)"},{"key":"10.1111\/ijcp.12088-BIB27|cit27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1185\/03007990902801360","article-title":"Secondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: risk factors, treatment and target level attainment","volume":"25","author":"V\u00f6ller","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/ijcp.12088-BIB28|cit28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/HJR.0b013e32832a4e25","article-title":"Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry","volume":"16","author":"Gitt","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1111\/ijcp.12088-BIB29|cit29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2337\/diacare.28.3.600","article-title":"Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?","volume":"28","author":"Shah","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12088-BIB30|cit30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/HYPERTENSIONAHA.111.174367","article-title":"Treatment intensification in a hypertension telemanagement trial: clinical inertia or good clinical judgment?","volume":"58","author":"Crowley","year":"2011","journal-title":"Hypertension"},{"key":"10.1111\/ijcp.12088-BIB31|cit31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archinte.166.5.507","article-title":"An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8","volume":"166","author":"Ziemer","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/ijcp.12088-BIB32|cit32","article-title":"Arzneimittelverordnung: KV Berlin kritisiert neue Richtgr\u00f6\u00dfen","volume":"108","author":"Mei\u00dfner","year":"2011","journal-title":"Dtsch Arztebl"},{"key":"10.1111\/ijcp.12088-BIB33|cit33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMp1106689","article-title":"Weighing the benefits of high-dose simvastatin against the risk of myopathy","volume":"365","author":"Egan","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12088-BIB34|cit34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjopharm.2011.02.004","article-title":"A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity","volume":"9","author":"Gellad","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1111\/ijcp.12088-BIB35|cit35","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1445-5994.2011.02534.x","article-title":"Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in females","volume":"41","author":"Driscoll","year":"2011","journal-title":"Intern Med J"},{"key":"10.1111\/ijcp.12088-BIB36|cit36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1741826710389366","article-title":"Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study","volume":"18","author":"Tomasik","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1111\/ijcp.12088-BIB37|cit37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/08037051.2010.483053","article-title":"Cardiovascular risk factors are not treated to target in hypertensive patients in primary care","volume":"19","author":"Nieburg","year":"2010","journal-title":"Blood Press"},{"key":"10.1111\/ijcp.12088-BIB38|cit38","first-page":"e13","article-title":"Attainment of Canadian Diabetes Association recommended targets in patients with type 2 diabetes: a study of primary care practices in St John\u2019s, Nfld","volume":"56","author":"McCrate","year":"2010","journal-title":"Can Fam Physician"},{"key":"10.1111\/ijcp.12088-BIB39|cit39","volume-title":"Adverse Reactions Working Party: Second Report","author":"Committee of Safety of Medicines","year":"1986"},{"key":"10.1111\/ijcp.12088-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1742-1241.2009.02099.x","article-title":"The mechanism and mitigation of niacin-induced flushing","volume":"63","author":"Kamanna","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1111\/ijcp.12088-BIB41|cit41","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7326\/0003-4819-140-11-200406010-00014","article-title":"Observational studies of treatment effectiveness: some cautions","volume":"140","author":"Laupacis","year":"2004","journal-title":"Ann Intern Med"},{"issue":"Suppl. 1","key":"10.1111\/ijcp.12088-BIB42|cit42","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc11-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12088-BIB43|cit43","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2337\/dc11-1369","article-title":"Effect of extended-release niacin on new-onset diabetes among hyperlipidemic patients treated with ezetimibe\/simvastatin in a randomized controlled trial","volume":"35","author":"Guyton","year":"2012","journal-title":"Diabetes Care"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12088","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:06:30Z","timestamp":1643349990000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12088"}},"subtitle":["Niacin\/laropiprant in clinical practice"],"short-title":[],"issued":{"date-parts":[[2013,2,26]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12088","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,26]]},"assertion":[{"value":"2013-02-26","name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}